PositiveNaija Public Alert 42: NAFDAC Notifies on Prohibition of Use and Sale of Bledine Infant Cereals by Chadian Authorities

PositiveNaija Public Alert 42: The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a report received regarding the prohibition of the use, distribution and sale of Bledine Infant Cereals, manufactured by Danone Group, a French multinational food and beverage company, by the Chadian authorities.

Continue reading PositiveNaija Public Alert 42: NAFDAC Notifies on Prohibition of Use and Sale of Bledine Infant Cereals by Chadian Authorities

PositiveNaija Public Alert 41: NAFDAC Notifies on Substandard and Falsified (SF) BETACLOX found in Nigeria

PositiveNaija Public Alert 41: The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about a suspected substandard and falsified (SF) pharmaceutical product identified within the drug supply chain. The product in question, BETACLOX (a combination of ampicillin and cloxacillin), contains fraudulent registration details and comes from an unverified source, posing significant risks to public health.

Continue reading PositiveNaija Public Alert 41: NAFDAC Notifies on Substandard and Falsified (SF) BETACLOX found in Nigeria

PositiveNaija Public Alert 40: NAFDAC Notifies on Substandard batches of Annmox (Amoxicillin suspensions 125mg/5ml) and Jawamox (Amoxicillin suspension 125mg/5ml) manufactured by Jawa International Ltd due to low Active Pharmaceutical Ingredient (API) content

PositiveNaija Public Alert 40: The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public about the mop up of batches of confirmed substandard Annmox (Batch 360M) and Jawamox (Batch 4231M & 4290M) Suspensions.

The products failed laboratory analysis due to low Active Pharmaceutical Ingredient (API) content.

The company has been directed to recall the failed batches from circulation.

Continue reading PositiveNaija Public Alert 40: NAFDAC Notifies on Substandard batches of Annmox (Amoxicillin suspensions 125mg/5ml) and Jawamox (Amoxicillin suspension 125mg/5ml) manufactured by Jawa International Ltd due to low Active Pharmaceutical Ingredient (API) content

PositiveNaija Public Alert 39: NAFDAC Notifies on Substandard Astamocil (Amoxicillin Suspension 125mg/5ml), Batch No. 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension), Batch Nos: 0503024 & 0501724, manufactured by Sam-Ace Ltd in Nigeria

PositiveNaija Public Alert 39: The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public about the recall of two products: Astamocil (Amoxicillin Suspension 125mg/5ml), Batch 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension 228.5 mg), Batches 0503024 and 0501724, manufactured by Sam-Ace Ltd in Nigeria.

Continue reading PositiveNaija Public Alert 39: NAFDAC Notifies on Substandard Astamocil (Amoxicillin Suspension 125mg/5ml), Batch No. 826024, and Astamentin (Amoxicillin/Clavulanic Acid Suspension), Batch Nos: 0503024 & 0501724, manufactured by Sam-Ace Ltd in Nigeria

PositiveNaija Public Alert 38: NAFDAC Notifies on the Sale of Counterfeit Cialis Tablet 20mg in Nigeria

PositiveNaija Public Alert 38: The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the distribution and sale of counterfeit Cialis 20mg tablets in Nigeria.

Continue reading PositiveNaija Public Alert 38: NAFDAC Notifies on the Sale of Counterfeit Cialis Tablet 20mg in Nigeria

PositiveNaija Public Alert 37: NAFDAC Notifies on the Discontinuation of the Production of Penicillin-Based Moiety by Miraflash

PositiveNaija Public Alert 37: The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the decision to discontinue the production of penicillin-based products by Miraflash Nigeria Limited.

This decision is taken as a corrective measure and closure of a critical observation made during a GMP inspection conducted in the company by a team of NAFDAC officers in June 2024.

Continue reading PositiveNaija Public Alert 37: NAFDAC Notifies on the Discontinuation of the Production of Penicillin-Based Moiety by Miraflash

PositiveNaija Public Alert 36: NAFDAC Notifies on the Presence of an Unauthorized/ Unregistered Darzalex (Daratumumab) 1800mg/15ml vial SC Injection in Nigeria

PositiveNaija Public Alert 36: The National Agency for Food and Drugs Administration and Control (NAFDAC) is alerting the public on the sale of an unauthorized and unregistered brand of Daratumumab formulation in Nigeria.

An internal investigation conducted by Johnson & Johnson revealed that there are two different packaging designs for their Daratumumab product. One design is intended for the Indian market, while the other is meant for the Arab market.

Continue reading PositiveNaija Public Alert 36: NAFDAC Notifies on the Presence of an Unauthorized/ Unregistered Darzalex (Daratumumab) 1800mg/15ml vial SC Injection in Nigeria